Oncocyte Corporation Announces Pricing of Public Offering :

IRVINE, Calif., April 13, 2022 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), (“Oncocyte” or the “Company”), announced today the pricing of an...

Related Keywords

New York , United States , Bob Yedid , Megan Kernan , Lifesci Advisors , Company Determa , Company Annual Report On Form , Needham Company , Exchange Commission , Syndicate Prospectus Department , Oncocyte Corporation , Insight Genetics Inc , Chronix Biomedical Inc , Life Technologies Corporation , Oncocyte Corporation Nasdaq , Collaboration Agreement , Thermo Fisher Scientific , Oncomine Comprehensive Assay Plus , Integrated Sequencer , Purification System , Chronix Biomedical , Insight Genetics , Private Securities Litigation Reform Act , Risk Factors , Annual Report , Sci Advisors , Nasdaq Ocx ,